Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy
about
Anticoagulants and Statins As Pharmacological Agents in Free Flap Surgery: Current RationalePleiotropic effects of statinsInvestigating the effects of statins on cellular lipid metabolism using a yeast expression system.Statin-induced rhabdomyolysis: a comprehensive review of case reports.Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International StudyEffects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapyRho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms.Transgelin 2 participates in lovastatin-induced anti-angiogenic effects in endothelial cells through a phosphorylated myosin light chain-related mechanism.Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage.Role of nitric oxide and CCAAT/enhancer-binding protein transcription factor in statin-dependent induction of heme oxygenase-1 in mouse macrophages.Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductase.Redox signalling and cardioprotection: translatability and mechanismChronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection functionStatin intake is associated with MMP-1 level in gingival crevicular fluid of patients with periodontitis.Pleiotropic effects of statins. - Basic research and clinical perspectives -.Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS)Pleiotropic vasoprotective effects of statins: the chicken or the egg?Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.Novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: a patent review.Oxidative stress and endothelial dysfunction: therapeutic implications.Emerging treatment options for benign prostatic obstruction.Molecular pathology of familial hypercholesterolemia, related dyslipidemias and therapies beyond the statins.Statins and vein graft failure in coronary bypass surgery.Statins and pregnancy: between supposed risks and theoretical benefits.Signal transduction in Plasmodium-Red Blood Cells interactions and in cytoadherence.Can statins improve outcomes after isolated cardiac valve surgery? A systematic literature review.Rho-kinase: regulation, (dys)function, and inhibition.Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies.Atorvastatin ameliorates LPS-induced inflammatory response by autophagy via AKT/mTOR signaling pathway.Simvastatin inhibits protein isoprenylation in the brain.Cerivastatin represses atherogenic gene expression through the induction of KLF2 via isoprenoid metabolic pathways.Rac1 in human diseases: The therapeutic potential of targeting Rac1 signaling regulatory mechanisms.Effects of Different Types of Statins on Lipid Profile: A Perspective on Asians.Effects of Simvastatin Beyond Dyslipidemia: Exploring Its Antinociceptive Action in an Animal Model of Complex Regional Pain Syndrome-Type I.Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products.Aqueous extract of Yerba Mate tea lowers atherosclerotic risk factors in a rat hyperlipidemia model.Efficacy and safety of rosuvastatin in late-onset hypogonadism patients with dyslipidaemia.
P2860
Q26776077-A7C54086-A68A-469C-AD75-67EE8775E5BEQ26783220-797C6C57-A304-4401-A021-F13C1135AFAFQ33521217-75A224DF-8717-411D-B663-A1148466EA67Q33551640-7CD56B3D-8439-45A8-8AEA-D8048CB86AAEQ33630826-0E641DB9-D95F-40EC-9B3C-54F79DED3884Q33822217-B651318A-9B66-4BF9-B050-47EF985DF132Q34362144-F4E97B62-2B0F-4D7E-9EBC-FF2118DF32AAQ34380392-32A93D83-C933-46DB-9092-0F5B603140AEQ34441557-0FB4A67A-E823-4D54-8780-CC881F216F9FQ34669052-8FE96C47-D380-4116-BDA5-EABC572277CEQ34745152-EC01F27E-66DE-4721-A0E8-7DC8EF86B0A9Q34823543-A52E802B-1B24-46C5-83B0-D20A9542C71CQ35017735-F9980F44-0F4D-47AA-956F-4A51A2E2F744Q35286322-69B0B80F-16E5-46E1-B0DA-D123CB74435FQ35538919-ABB3A84F-6F20-4D10-9C62-924619307ACDQ36984463-7E91D802-2185-4996-9F1B-32B31022B7CBQ37252114-25C07EE2-65F4-496F-B25C-38E14E2F6111Q37289807-ADB3BDC9-6D66-46E1-828D-94E9DA455B1EQ37403235-AFA4C60A-80A1-4AB0-A486-93B749AEC627Q37734257-A8F7B088-1DD9-4F2F-8C96-A9099FA598C8Q37826757-0B6946D8-DE51-4013-AED5-3C862CC8200FQ37834017-BB8A312E-5553-4B0C-8373-FB801C237739Q37863036-3496A8E0-F4D0-4636-91B9-56F87F3A93F3Q37972887-DC94D525-58A2-44E2-A8DB-785A00C78030Q37983344-44C19598-5DB6-4D61-9AD5-9E5F766AD051Q38000338-721291B3-4205-4185-B6B6-75C4DA619B0AQ38013546-F73179CC-89AE-4F14-9F78-E1D04BC53C0FQ38106668-B7E676EB-408D-4C65-87C6-B7DEE14199D3Q38129373-8D09E8AF-0A94-4E34-A3F5-04165A543B34Q38471162-C3C679E2-5312-406E-9E81-7ECA556941D2Q38538716-0143357C-2246-41EC-96F7-3C2D5FEB1235Q38644108-28393823-2DFE-4C16-A769-698286F98A0CQ38770832-7BA1C504-DDC9-4D15-B9EC-099A4D00118CQ38820321-B3666A68-1507-4694-9DA0-F70E023A5EB4Q38839225-D2F0EE7D-C60C-42D6-876A-D69D39F45598Q41391827-78DB7543-46F0-492D-8DB2-5BFFFC926A3BQ41470255-C736E149-C67E-4FD8-9149-731E68CD0683Q41894332-09732F0F-DCCC-4C54-99BB-BF8602D81225Q45237861-7ECE2A93-E5F0-479F-8509-A74AE206F1A8Q45860083-E7B95BC1-4511-4C33-80EB-0662C0CC6516
P2860
Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy
@ast
Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy
@en
type
label
Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy
@ast
Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy
@en
prefLabel
Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy
@ast
Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy
@en
P2860
P1476
Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy
@en
P2093
James K Liao
P2860
P304
P356
10.2174/138161209787315684
P577
2009-01-01T00:00:00Z